Linguamatics specializes in AI-enabled language and translation solutions tailored specifically for the healthcare and life sciences sectors. Their offerings include advanced Natural Language Processing (NLP) and Neural Machine Translation (NMT) technologies, which are designed to streamline clinical documentation and translation workflows. With over 20 years of experience, Linguamatics provides tools that facilitate rapid access to translation services across more than 150 languages, enabling healthcare organizations to manage global clinical trials efficiently. Their solutions are built to reduce costs and improve the quality of translations, leveraging both AI and human expertise to ensure high accuracy and compliance with industry standards.

The company's technology suite includes the Linguamatics Hub, a centralized portal for managing translation projects, and Linguamatics Translate, which offers machine translation capabilities specifically for clinical documentation. This suite is complemented by their award-winning NLP technology, which has been utilized by leading pharmaceutical companies to enhance clinical trial processes, optimize protocol design, and extract valuable insights from vast amounts of data. By focusing on the unique needs of the healthcare sector, Linguamatics aims to overcome language and cultural barriers, ultimately improving patient outcomes and accelerating the pace of innovation in clinical research.

United Kingdom

Founded in 2001, Linguamaticsusesnatural language processing (NLP)-based text mining for high-value knowledge discovery and decision support.

Linguamatics

Company Details